Emicizumab-kxwh Subcutaneous and Irinotecan Hydrochloride
Determining the interaction of Emicizumab-kxwh Subcutaneous and Irinotecan Hydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: irinotecan
Brand name: Camptosar
Synonyms: Irinotecan (Conventional), Irinotecan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Irinotecan Intravenous
- Emicizumab-kxwh Subcutaneous-Irinotecan liposomal
- Emicizumab-kxwh Subcutaneous-Irinotecan liposome Intravenous
- Emicizumab-kxwh Subcutaneous-Iron 100/C
- Emicizumab-kxwh Subcutaneous-Iron 21/7
- Emicizumab-kxwh Subcutaneous-Iron and Docusate
- Irinotecan Hydrochloride-Emla
- Irinotecan Hydrochloride-Emla Topical
- Irinotecan Hydrochloride-Emo-Cort Scalp Solution Topical application
- Irinotecan Hydrochloride-Emo-Cort Topical application
- Irinotecan Hydrochloride-Emoquette
- Irinotecan Hydrochloride-Empagliflozin